0001214659-22-003987.txt : 20220315 0001214659-22-003987.hdr.sgml : 20220315 20220315191226 ACCESSION NUMBER: 0001214659-22-003987 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220315 FILED AS OF DATE: 20220315 DATE AS OF CHANGE: 20220315 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GUSTAFSON MARK CENTRAL INDEX KEY: 0001303996 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40483 FILM NUMBER: 22742784 MAIL ADDRESS: STREET 1: 10691 ROSECROFT CRESCENT CITY: RICHMOND STATE: A1 ZIP: V7A 2H9 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Alzamend Neuro, Inc. CENTRAL INDEX KEY: 0001677077 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 811822909 STATE OF INCORPORATION: DE FISCAL YEAR END: 0430 BUSINESS ADDRESS: STREET 1: 3802 SPECTRUM BLVD, STREET 2: SUITE C112C CITY: TAMPA STATE: FL ZIP: 33612 BUSINESS PHONE: 844-722-6333 MAIL ADDRESS: STREET 1: 3802 SPECTRUM BLVD, STREET 2: SUITE C112C CITY: TAMPA STATE: FL ZIP: 33612 4 1 marketforms-55804.xml PRIMARY DOCUMENT X0306 4 2022-03-15 0001677077 Alzamend Neuro, Inc. ALZN 0001303996 GUSTAFSON MARK 3500 LENOX RD NE, SUITE 1500 ATLANTA GA 30326 true false false false Common Stock 2022-03-15 4 M false 50000 0 A 80000 D Restricted Stock Grant 2022-03-15 4 M false 50000 0 D 2022-03-15 Common Stock 50000 0 D Represents the vesting of restricted stock. Each restricted stock unit is the economic equivalent of one share of Common Stock, par value $0.0001, of Alzamend Neuro, Inc. 2,778 and 47,222 restricted shares previously vested on September 13, 2021 and October 13, 2021, respectively, with the final 50,000 shares of restricted stock vesting on March 15, 2022. /s/ Mark Gustafson 2022-03-15